Pages that link to "Q40190947"
Jump to navigation
Jump to search
The following pages link to Structure and function of the anaphylatoxins (Q40190947):
Displaying 50 items.
- Molecular cloning and characterization of the human anaphylatoxin C3a receptor (Q24311767) (← links)
- In Xenopus oocytes the human C3a and C5a receptors elicit a promiscuous response to the anaphylatoxins (Q24317538) (← links)
- Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus (Q24529541) (← links)
- Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica (Q30992825) (← links)
- Interaction of fucoidan with the proteins of the complement classical pathway. (Q33193054) (← links)
- A model for the interplay of inflammatory mediators in sepsis--a study in 48 patients (Q33402850) (← links)
- Complement-mediated acute effects of liposome-encapsulated hemoglobin (Q33537849) (← links)
- Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope (Q33538951) (← links)
- Complement activation and HLA-B27 (Q33560757) (← links)
- Protein losing enteropathy associated with collagen diseases (Q33563461) (← links)
- Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a. (Q33598236) (← links)
- Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species (Q33620267) (← links)
- Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis (Q33829523) (← links)
- Sulfation of tyrosine residues increases activity of the fourth component of complement (Q33838582) (← links)
- Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies (Q34080920) (← links)
- Complement deficiency (Q34099436) (← links)
- Efficient osteoclast differentiation requires local complement activation (Q34374041) (← links)
- Downsizing a human inflammatory protein to a small molecule with equal potency and functionality. (Q34386483) (← links)
- The complement system: history, pathways, cascade and inhibitors (Q34412336) (← links)
- Novel potential interacting partners of fibronectin in spontaneous animal model of interstitial cystitis (Q34510967) (← links)
- Expression and subcellular targeting of human complement factor C5a in Nicotiana species (Q34534970) (← links)
- Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg (Q34558356) (← links)
- Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors (Q35034275) (← links)
- The immunologic response to thermal injury (Q35193837) (← links)
- Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release (Q35586919) (← links)
- Interactions of immunoglobulins outside the antigen-combining site (Q35671707) (← links)
- Complement-mediated killing of microtumors in vitro (Q35753353) (← links)
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils (Q35815126) (← links)
- C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes (Q35856148) (← links)
- Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor (Q36278194) (← links)
- Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide (Q36401494) (← links)
- Conversion of murine Fabs isolated from a combinatorial phage display library to full length immunoglobulins (Q36692661) (← links)
- Serum complements and heart fatty acid binding protein in Bangladeshi patients with acute myocardial infarction (Q36800780) (← links)
- Biology of complement: the overture (Q36845167) (← links)
- Complement C3: A molecular mosaic of binding sites (Q37092607) (← links)
- Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex (Q37390308) (← links)
- Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement (Q37692311) (← links)
- Assays for complement activation. (Q38160856) (← links)
- Physiological and pathological aspects of circulating immune complexes (Q38620468) (← links)
- Complement activation during hemodialysis (Q38698334) (← links)
- Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal? (Q38724499) (← links)
- Leishmanial protein kinases phosphorylate components of the complement system. (Q39065003) (← links)
- Complement in the pathophysiology and diagnosis of human diseases (Q39487716) (← links)
- The chemistry and biology of complement receptors (Q40118351) (← links)
- The membrane attack complex (Q40190950) (← links)
- The role of complement in pregnancy-induced hypertensive disease (Q40620511) (← links)
- C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. (Q40684870) (← links)
- Monitoring of immunotherapy with cytokines or monoclonal antibodies (Q40689787) (← links)
- Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor (Q40912578) (← links)
- Evidence that the receptor for C4a is distinct from the C3a receptor (Q41063783) (← links)